Genesis Cancer Care Institute Treatment Trials - Genesis Health System

Cancer Clinical Trials

Clinical trials are research studies in which people help doctors find ways to improve health and cancer care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose or treat cancer. Learn more about the different types and phases of clinical trials.

Why should I participate in a clinical trial?

Today it is possible to enroll in a clinical trial as the first step in your treatment after a cancer diagnosis. There are literally hundreds of trials available across the country. In fact, many of our most effective treatments used today for breast, colon, rectal and childhood cancers are the result of recent successes in clinical trials. As a participant a patient has the opportunity to help further the cause for other cancer patients, and possibly be helped by the treatments they receive. Participation in a clinical trial is voluntary.

Below is a listing current treatment clinical trials for cancer offered through the Genesis Cancer Care Institute and Iowa Cancer Specialists.

Each trial below is linked to a complete description provided by the National Cancer Institute. If you need assistance with this process, contact us.

You may search for other clinical trials through the following links: National Cancer Institute Clinical Trial Search; Emerging Med; Trial Check; or Center Watch.

Showing 1-5 of 5

Sorted By:

  • Breast Cancer: NRG-BR003

    The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin.

  • Colon Cancer: A021502 (Adjuvant Treatment)

    This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair.

  • Lung (Non-Small Cell) Cancer: A151216

    The purpose of this research study is to look at lung cancer patients’ tumors that were removed by surgery for certain genetic changes, and to possibly offer these patients a treatment study with drugs that may specifically target tumors that have these genetic changes.

  • Lung (Non-Small Cell) Cancer: E4512

    The purpose of this research study is to compare any good and bad effects of using the study drug, crizotinib (also known as XALKORI®), after completion of surgery and, in some cases, after chemotherapy and/or radiation therapy for patients with ALK-positive non-small cell lung cancer.

  • Lung (Non-Small Cell) Cancer: LUNGMAP

    This study is for patients that have advanced non-small cell lung cancer and has two steps: the initial screening step where we will examine tumor tissue and the sub-study treatment step where patients will be assigned to a treatment sub-study that is chosen based on the screening results.

Contact Us

For more information about our cancer services, please contact:



or contact us online

Cancer Navigators

Do you or a loved one have cancer? Let our Cancer Navigators guide the way. Call us today.


Learn More


When you join hands with your family, friends, and neighbors in their fight against cancer... you let them know they are not alone.

GIVE Today

Related Locations